Armeniacae semen amarum: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics

Armeniacae semen amarum—seeds of Prunus armeniaca L. (Rosaceae) (ASA), also known as Kuxingren in Chinese, is a traditional Chinese herbal drug commonly used for lung disease and intestinal disorders. It has long been used to treat coughs and asthma, as well as to lubricate the colon and reduce constipation. ASA refers to the dried ripe seed of diverse species of Rosaceae and contains a variety of phytochemical components, including glycosides, organic acids, amino acids, flavonoids, terpenes, phytosterols, phenylpropanoids, and other components. Extensive data shows that ASA exhibits various pharmacological activities, such as anticancer activity, anti-oxidation, antimicrobial activity, anti-inflammation, protection of cardiovascular, neural, respiratory and digestive systems, antidiabetic effects, and protection of the liver and kidney, and other activities. In clinical practice, ASA can be used as a single drug or in combination with other traditional Chinese medicines, forming ASA-containing formulas, to treat various afflictions. However, it is important to consider the potential adverse reactions and pharmacokinetic properties of ASA during its clinical use. Overall, with various bioactive components, diversified pharmacological actions and potent efficacies, ASA is a promising drug that merits in-depth study on its functional mechanisms to facilitate its clinical application

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion

The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied. In a multicenter trial in China, we enrolled patients with ischemic stroke without occlusion of large or medium-sized vessels and with a National Institutes of Health Stroke Scale score of 5 or more and at least one moderately to severely weak limb. Eligible patients had any of four clinical presentations: ineligible for thrombolysis or thrombectomy and within 24 hours after the patient was last known to be well; progression of stroke symptoms 24 to 96 hours after onset; early neurologic deterioration after thrombolysis; or thrombolysis with no improvement at 4 to 24 hours. Patients were assigned to receive intravenous tirofiban (plus oral placebo) or oral aspirin (100 mg per day, plus intravenous placebo) for 2 days; all patients then received oral aspirin until day 90. The primary efficacy end point was an excellent outcome, defined as a score of 0 or 1 on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days. Secondary end points included functional independence at 90 days and a quality-of-life score. The primary safety end points were death and symptomatic intracranial hemorrhage. A total of 606 patients were assigned to the tirofiban group and 571 to the aspirin group. Most patients had small infarctions that were presumed to be atherosclerotic. The percentage of patients with a score of 0 or 1 on the modified Rankin scale at 90 days was 29.1% with tirofiban and 22.2% with aspirin (adjusted risk ratio, 1.26; 95% confidence interval, 1.04 to 1.53, P = 0.02). Results for secondary end points were generally not consistent with the results of the primary analysis. Mortality was similar in the two groups. The incidence of symptomatic intracranial hemorrhage was 1.0% in the tirofiban group and 0% in the aspirin group. In this trial involving heterogeneous groups of patients with stroke of recent onset or progression of stroke symptoms and nonoccluded large and medium-sized cerebral vessels, intravenous tirofiban was associated with a greater likelihood of an excellent outcome than low-dose aspirin. Incidences of intracranial hemorrhages were low but slightly higher with tirofiban

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Toward New Ways of Communicating Wine Values: from Autoregulation to Public Relations and Social Responsibility

El presente artículo diagnostica las vulnerabilidades comunicativas del sector vitivinícola y ofrece una visión amplia y multidisciplinar del problema de la comunicación del sector. La publicidad, los eventos, la investigación, desarrollo e innovación (I+D+i), la protección de la salud del consumidor, el turismo, la gastronomía, el desarrollo sostenible, la antropología cultural, la neurociencia y su relación con el conocimiento de las emociones, y la socialización del consumo de vino, son variables que se deben considerar de modo sistémico a la hora de enfocar el problema de la actual asimetría comunicativa que parece caracterizar al sector vitivinícola en general, aunque afortunadamente ya se constatan algunas experiencias comunicativas nuevas interesantes. Al respecto se brindan reflexiones y recomendaciones sobre la comunicación de los valores del vino, producto de un trabajo exploratorio y descriptivo, basado en la revisión documental científica, técnica y profesional especializada, así como en el análisis de diversas campañas relacionadas con el vino y entrevistas a líderes del sector, tanto productores como responsables de la comunicación y comercialización de la zona de la Comunidad Valenciana (España), y como contraste con Chile y Argentina.This paper presents a diagnosis of communicative vulnerabilities of the wine sector and a multidisciplinary vision of communication problem in this sector. Advertising, events, R&D, health, tourism, gastronomy, sustainable development, cultural anthropology, neuroscience, socialization of wine consumption, are variables to be considered from a systemic perspective oriented to solve the actual communicative asymmetry which seems to characterize the wine sector in general. This work proposes recommendations about Public Relations and communicative ecosystem based on the results of an exploratory and descriptive research focused on literature review, Communication campaigns review, questionnaires and interviews addressed to key informants located geographically in Valentian community- Spain, Chile, and Argentina

Anisotropic honeycomb stack metamaterials of graphene for ultrawideband terahertz absorption

Graphene aerogels have implied great potential for electromagnetic wave absorption. However, the investigation of their design for broadband absorption in the terahertz (THz) range remains insufficient. Here, we propose an anisotropic honeycomb stack metamaterial (AHSM) based on graphene to achieve ultrawideband THz absorption. The absorption mechanism is elucidated using the effective medium method, offering deeper physics insights. At low THz frequencies, the impedance matching from the air to the AHSM can be improved by reducing the chemical potential of graphene for high absorption. There is a suppression of absorption at the intermediate frequencies due to constructive interference, which can be avoided by shortening the sizes of honeycomb edges. With the aim to elevate absorption at high frequencies, one can increase the stack layer number to enhance multiple reflections and destructive interference within the metastructure. Based on the above principles, we design an AHSM that achieves a broadband absorbance of over 90 % from 1 THz to 10 THz. This absorption can tolerate a wide range of incident angles for both TE and TM wave excitations. Our research will provide a theoretical guide to future experimental exploration of graphene aerogels for THz metamaterial absorber applications

Reconfigurable high-Q terahertz filtering of VO2-based metamaterials using optical tunneling

Up to date, reconfigurable terahertz (THz) band-pass filters based on the design of metamaterials with vanadium dioxide (VO2) have been investigated extensively. However, VO2-based THz metamaterials with high-quality tunable narrowband transmission and good stop-band rejection have yet to be reported, which are essential for THz wave filtering components or systems. Here, we propose a reconfigurable filter in combination with a dielectric metastructure and a VO2 thin film. Utilizing the optical tunneling effects of a cavity layer, the filter has a high band-pass transmission up to 98% at 0.246 THz with a narrow bandwidth of 0.0009 THz, an ultra-high Q-factor of 273, and two broad nearly-suppressed sidebands. The transmission intensity can be modulated by the phase transition of VO2, and the modulation depth is as high as 96.4%. By efficiently tuning the cavity layer thickness, the filter can be designed for a series of transmission wavelengths and further accomplish the switch between the narrow band-pass filtering and wideband reflection. Moreover, the manipulation of the incident angle and polarization can be adopted as an additional degree to achieve a similar switching function. Our study implies a potential for developing various THz applications, where reconfigurable high-Q THz filtering is required

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis

Objective. CD161 has been identified as a marker of human IL-17-producing T cells that are implicated in the pathogenesis of rheumatoid arthritis (RA). This study aimed to investigate the potential link between the percentage of CD161+ T cells and disease activity in RA patients. Methods. Peripheral blood (PB) from 54 RA patients and 21 healthy controls was evaluated. Paired synovial fluid (SF) (n = 17) was analyzed. CD161 expression levels on CD4+, CD8+, and CD4−CD8− T cells were assessed by flow cytometry. Results. The percentage of CD4+CD161+ T cells in RA SF was higher than RA PB, and it was positively correlated with DAS28, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). CD4−CD8−CD161+ T cell percentage was decreased in RA PB and was further reduced in RA SF, and its level in SF was inversely correlated with DAS28, ESR, and CRP. However, CD8+CD161+ T cell percentage was neither changed in RA PB and SF nor correlated with disease activity indices. Conclusion. An increased CD4+CD161+ T cell percentage and a decreased CD4−CD8−CD161+ T cell percentage are present in RA SF and are associated with disease activity, and the accumulation of CD4+CD161+ T cells in SF may contribute to the local inflammation of RA

Chinese Colorless HPHT Synthetic Diamond Inclusion Features and Identification

Chinese HPHT diamonds have improved dramatically in recent years. However, this brings a challenge in identifying type IIa colorless diamonds. In this study, eleven HPHT and three natural, colorless, gem-quality IIa diamonds were analyzed using magnified observation, Raman, PL and chemical element analysis. The results show that only HPHT samples possessed kite-like inclusions and lichenoid inclusions, as verified by their complex Raman spectra (100–750 cm−1). Through PL mapping, HPHT and natural IIa diamonds were distinguished by their growth environments, which were reflected by PL peaks at 503, 505, 575, 637, 693, 694 and 737 nm. The chemical components of HPHT IIa diamond carbide inclusions are mainly Fe, Co, Ni and Mn, but those of Natural IIa are mainly Fe and Ni. As a result, the chemical components can be used to distinguish a natural colorless IIa diamond from a synthetic diamond

Chinese Colorless HPHT Synthetic Diamond Inclusion Features and Identification

Chinese HPHT diamonds have improved dramatically in recent years. However, this brings a challenge in identifying type IIa colorless diamonds. In this study, eleven HPHT and three natural, colorless, gem-quality IIa diamonds were analyzed using magnified observation, Raman, PL and chemical element analysis. The results show that only HPHT samples possessed kite-like inclusions and lichenoid inclusions, as verified by their complex Raman spectra (100&ndash;750 cm&minus;1). Through PL mapping, HPHT and natural IIa diamonds were distinguished by their growth environments, which were reflected by PL peaks at 503, 505, 575, 637, 693, 694 and 737 nm. The chemical components of HPHT IIa diamond carbide inclusions are mainly Fe, Co, Ni and Mn, but those of Natural IIa are mainly Fe and Ni. As a result, the chemical components can be used to distinguish a natural colorless IIa diamond from a synthetic diamond